Wong Hing C 4
4 · HCW Biologics Inc. · Filed Sep 10, 2021
Insider Transaction Report
Form 4
Wong Hing C
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2021-09-08+800,000→ 800,000 totalExercise: $4.31Exp: 2031-09-07→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]The option will vest as follows: 20% will vest on September 8, 2022, 20% will vest on September 8, 2023, 25% will vest on September 8, 2024 and 35% will vest on September 8, 2025.